CRISPR

Chicago, July 28, 2023 (GLOBE NEWSWIRE) -- In the near future, the CRISPR industry is poised for transformative breakthroughs that will revolutionize medicine, agriculture, and biotechnology. With continuous advancements in CRISPR…

Pune, India, July 25, 2023 (GLOBE NEWSWIRE) -- According to Recently Published Report by The Insight Partners, “Mice Model Market Size Report and Forecast to 2028 - COVID-19 Impact and Global Analysis by Type, Service, Technology,…

When bacteria are attacked by a virus, they can defend themselves with a mechanism that fends off the genetic material introduced by the intruder. The key is CRISPR-Cas protein complexes. It is only in the last decade that their function…

Artificial intelligence can predict on- and off-target activity of CRISPR tools that target RNA instead of DNA, according to new research published in Nature Biotechnology. The study by researchers at New York University, Columbia…

CRISPR gene editing is a breakthrough that has been used to treat diseases such as sickle cell anemia, leukemia and genetic disorders, but it has challenges that limit its broad utility. Identifying the root of those issues led a research…

In 2008, a fruit fly known as the spotted-wing drosophila made its way from Southeast Asia to the continental US, likely hitching a ride on fruit shipments. First detected in California raspberry fields, the insect rapidly spread to other…

Pune, India, June 23, 2023 (GLOBE NEWSWIRE) -- According to our latest study on "Genome Editing Market Size Report, Forecast to 2028 – COVID-19 Impact and Global Analysis – by Technology, Application, and End User,” the market size is…

Extended Phase 1 data reinforce the potential of NTLA-2002 to be a functional cure for people living with hereditary angioedema (HAE)Across all patients (n=10), a single dose of NTLA-2002 led to a 95% mean reduction in monthly HAE attack…

By LAURA UNGAR - AP Science Writer The lone volunteer in a gene-editing study targeting a rare form of Duchenne muscular dystrophy likely died after having a reaction to the virus that…

Currently, very few heritable diseases have gene therapies that have been approved by the FDA. One therapy, called Zolgensma, treats spinal muscular atrophy in newborns and children up to age two. But halting the disease in childhood may…